Successful desensitization to natalizumab using a 1-solution protocol

Ann Allergy Asthma Immunol. 2017 Jan;118(1):113-114. doi: 10.1016/j.anai.2016.10.009. Epub 2016 Nov 15.

Authors

Eva Pérez-Rodríguez¹, Miguel Ángel Hernández-Pérez², Juan Antonio Martínez-Tadeo³

Affiliations

¹ Service of Allergy and Clinical Immunology, Nuestra Señora de la Candelaria University Hospital, Santa Cruz de Tenerife, Spain. Electronic address: evperrod@gobiernodecanarias.org.
² Service of Neurology, Multiple Sclerosis Unit, Nuestra Señora de la Candelaria University Hospital, Santa Cruz de Tenerife, Spain.
³ Service of Allergy and Clinical Immunology, Nuestra Señora de la Candelaria University Hospital, Santa Cruz de Tenerife, Spain.

PMID: 27864092
DOI: 10.1016/j.anai.2016.10.009

No abstract available

MeSH terms

Adult
Desensitization, Immunologic / methods
Drug Hypersensitivity / immunology*
Female
Humans
Natalizumab / immunology*

Substances

Natalizumab